This article explores the root causes of Adderall shortage in the US, the personal stories and impact of the shortage on patients, and possible solutions and alternatives for ADHD treatment. This article highlights the role of pharmaceutical companies, regulators, and patients in the Adderall shortage problem and calls for collective action to help address this issue.